NCT06619340
EXPAREL IPSA Block in Knee Arthroplasty
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentCampbell ClinicInvestigator-initiated
~10 participants
Updated 2024-10-01 on ClinicalTrials.gov
What's tested:Exparel
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain Assessment - 24hr recall
Measured over Study Enrollment, Post-operative Day 1, Post-operative Day 2, Post-operative Day 3, Post-operative Day 14, Post-operative Day 42
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- William Mihalko, MD, PhD · PRINCIPAL_INVESTIGATOR · Campbell Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Pain Assessment - 24hr recallStudy Enrollment, Post-operative Day 1, Post-operative Day 2, Post-operative Day 3, Post-operative Day 14, Post-operative Day 42
On a 0-10 scale, record worst pain in the last 24 hours and average pain in the last 24 hours, with 0 being no pain at all and 10 being the worst pain possible.
- Pain Assessment - current painStudy Enrollment, On Admission to Surgery, on Post Anesthesia Care Unit (PACU) Admission, every 15 minutes from PACU admission to discharge home, 12 hours after surgery, Post-operative Day (POD) 1, POD 2, POD 3, POD 14, POD 42
On a 0-10 scale, record current pain level, with 0 being no pain at all and 10 being the worst pain possible.